The UK government plans to turbocharge the life sciences sector using policy levers to enhance research and development, innovation hubs, and private fundraising.
In this piece, Michael Bloch explores how refinements to industrial strategy, equity capital markets, pension savings, and university spin-outs can support innovative scale-up businesses.
The UK life sciences sector has significant potential due to its leading research clusters, major domestic businesses, and valuable patient data from the NHS. There are steps policymakers, universities and financiers can take to improve the investment ecosystem, enabling earlier-stage innovators to scale and eventually list.
Please see full publication below for more information.
